The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Culture‐independent analysis of the gut microbiota in colorectal cancer and polyposis
Abstract
Summary: A role for the intestinal microbiota is routinely cited as a potential aetiological factor in colorectal cancer initiation and progression. As the majority of bacteria in the gut are refractory to culture we investigated this ecosystem in subjects with colorectal cancer and with adenomatous polyposis who are at high risk of developing colorectal cancer, using culture‐independent methods. Twenty colorectal cancer and 20 polypectomized volunteers were chosen for this analysis. An exploration of the diversity and temporal stability of the dominant bacteria and several bacterial subgroups was undertaken using 16S rRNA gene denaturing gradient gel electrophoresis and ribosomal intergenic spacer analysis (RISA). Metabonomic analysis of the distal gut microbiota's environment was also undertaken. A significantly reduced temporal stability and increased diversity for the microbiota of subjects with colorectal cancer and polyposis was evident. A significantly increased diversity of the Clostridium leptum and C. coccoides subgroups was also noted for both disease groups. A clear division in the metabonome was observed for the colorectal cancer and polypectomized subjects compared with control volunteers. The intestinal microbiota and their metabolites are significantly altered in both colorectal cancer and polypectomized subjects compared with controls.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An increased diversity in Clostridium leptum (C.leptum) and Clostridium coccoides is present, while temporary instability and decreased complexity in composition are linked to colitis-associated CRC [48,49] .”
From Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis (2014) · cites this paper as [48]
In the citing paper
“Reduced temporal stability and increased diversity has been shown for the faecal microbiota of subjects with established CRC and polyposis,86”
From The gut microbiota and host health: a new clinical frontier (2016) · cites this paper as [86]
Citations
Cites
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Biodiversity and ecosystem functioning: Current knowledge and future challenges
Loreau, M., Naeem, S., Inchausti, P., Bengtsson, J., Grime, J. P., Hector, A., Hooper, D. U., Huston, M. A., Raffaelli, D., Schmid, B., et al. (2001) · Science · doi:10.1126/science.1064088 · Cited by 4,649
Genetic instabilities in human cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/25292 · Cited by 4,168 · cited 2×
“The majority (~90%) of colorectal cancers arise sporadically in a time-dependent manner through adenomatous polyp formation with the activation of oncogenes such as K-ras (Lengauer et al., 1998) and inactivation of tumour suppressor genes such as APC and p53 (Hope et al.”
BackgroundMLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy
Bax, A., & Davis, D. G. (1985) · Journal of Magnetic Resonance (1969) · doi:10.1016/0022-2364(85)90018-6 · Cited by 3,605
Development of the Human Infant Intestinal Microbiota
Palmer, C., Bik, E. M., DiGiulio, D. B., Relman, D. A., & Brown, P. O. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050177 · Cited by 2,877
MICROBIAL ECOLOGY OF THE GASTROINTESTINAL TRACT
Savage, D. C. (1977) · Annual Review of Microbiology · doi:10.1146/annurev.mi.31.100177.000543 · Cited by 2,436
Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach
Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L., Nalin, R., Jarrin, C., Chardon, P., Marteau, P., et al. (2006) · Gut · doi:10.1136/gut.2005.073817 · Cited by 2,277
Suau, A., Bonnet, R., Sutren, M., Godon, J.-J., Gibson, G. R., Collins, M. D., & Doré, J. (1999) · Applied and Environmental Microbiology · doi:10.1128/aem.65.11.4799-4807.1999 · Cited by 1,490
Nübel, U., Engelen, B., Felske, A., Snaidr, J., Wieshuber, A., Amann, R., Ludwig, W., & Backhaus, H. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.19.5636-5643.1996 · Cited by 1,356
The microbiology of butyrate formation in the human colon
Pryde, S. E., Duncan, S. H., Hold, G. L., Stewart, C. S., & Flint, H. J. (2002) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2002.tb11467.x · Cited by 1,320
Cited by
Sorted by citations
Gut microbiota in health and disease
Sekirov, I., Russell, S. L., Antunes, L. C. M., & Finlay, B. B. (2010) · Physiological Reviews · doi:10.1152/physrev.00045.2009 · Cited by 4,182
“Several recent studies have used RISA to identify the enhanced colonization of certain bacterial species in patients with diseases like colorectal cancer (265) and IBD (151) compared with healthy controls.”
BackgroundResultInfluentialKostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., Clancy, T. E., Chung, D. C., Lochhead, P., Hold, G. L., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.007 · Cited by 2,718
“A few recent studies have performed case control studies of colorectal adenomas using 16S rRNA gene surveys with one noting fusobacterial enrichments in their patient cohort (McCoy et al., 2013; Sanapareddy et al., 2012; Scanlan et al., 2008; Shen et al., 2010).”
BackgroundThe gut microbiota and host health: a new clinical frontier
Marchesi, J. R., Adams, D. H., Fava, F., Hermes, G. D. A., Hirschfield, G. M., Hold, G., Quraishi, M. N., Kinross, J., Smidt, H., Tuohy, K. M., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-309990 · Cited by 2,302
“…CRC. 85 Reduced temporal stability and increased diversity has been shown for the faecal microbiota of subjects with established CRC and polyposis, 86 and now metagenomic and metatranscriptomic studies have identi fi ed an individualised oncogenic microbiome and speci fi c bacterial species that…”
BackgroundSelf-citationTerzić, J., Grivennikov, S., Karin, E., & Karin, M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.058 · Cited by 1,974
Yu, J. Q., Feng, Q., Wong, S. H., Zhang, D., Liang, Q. Y., Qin, Y., Tang, L., Zhao, H., Stenvang, J., Li, Y., et al. (2015) · Gut · doi:10.1136/gutjnl-2015-309800 · Cited by 1,273
The Human Microbiota in Health and Disease
Wang, B., Yao, M., Lv, L., Ling, Z., & Li, L. (2017) · Engineering · doi:10.1016/j.eng.2017.01.008 · Cited by 916
“In addition, studies have revealed the central role of microbial symbiosis in the development of many diseases [17], such as infection [18], liver diseases [19], gastrointestinal (GI) malignancy [20], metabolic disorders [7], respiratory diseases [21], mental or psychological diseases [22], and autoimmune diseases [23…”
BackgroundInfluence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer
Song, M., Chan, A. T., & Sun, J. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.06.048 · Cited by 752
Intestinal microbiota in human health and disease: the impact of probiotics
Gerritsen, J., Smidt, H., Rijkers, G. T., & de Vos, W. M. (2011) · Genes & Nutrition · doi:10.1007/s12263-011-0229-7 · Cited by 724
“…culturing Kanazawa et al. (1996) Faeces (3 time points) 20 Colon cancer patients 20 Polypectomized patients 20 Healthy individuals DGGE Scanlan et al. (2008) Colorectal biopsies 21 Individuals with adenomas 23 Individuals without adenomas T-RFLP Clone library sequencing…”
InfluentialGut microbiome-host interactions in health and disease
Kinross, J. K., Darzi, A. W., & Nicholson, J. K. (2011) · Genome Medicine · doi:10.1186/gm228 · Cited by 714
“An exploration of the dominant bacteria in patients with colorectal cancer (CRC) was recently undertaken [65].”
BackgroundProbiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice
Li, J., Sung, C. Y. J., Lee, N. P. Y., Ni, Y., Pihlajamäki, J., Panagiotou, G., & El-Nezami, H. S. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518189113 · Cited by 632
“This loss of community diversity can be explained by the tumor-induced dysbiosis in the gut bacteria community, consistent with previous findings that some diseases could lead to an imbalanced gut microbiota and decrease the ecological diversity in the gut (21, 22).”
ResultHomeostasis of the gut barrier and potential biomarkers
Wells, J. M., Brummer, R. J., Derrien, M., MacDonald, T. T., Troost, F. J., Cani, P. D., Théodorou, V., Dekker, J. P., Méheust, A., de Vos, W. M., et al. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00048.2015 · Cited by 638
Understanding the role of gut microbiome–host metabolic signal disruption in health and disease
Holmes, E., Li, J. V., Athanasiou, T., Ashrafian, H., & Nicholson, J. K. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.05.006 · Cited by 541
Self-citationInflammation and colorectal cancer: colitis-associated neoplasia
Grivennikov, S. I. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-012-0352-6 · Cited by 574
“Particularly, various bacteria from the Clostridia group can be enriched in IBD and even in some CRC samples [182] and changes in representation of various constituents of gut microbiota likely affects CAC development [138, 160].”
BackgroundTowards the Human Colorectal Cancer Microbiome
Marchesi, J. R., Dutilh, B. E., Hall, N., Peters, W. H. M., Roelofs, R., Boleij, A., & Tjalsma, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020447 · Cited by 552
“RISA was performed as described previously [23].”
MethodSelf-citationIntestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis
Tojo, R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i41.15163 · Cited by 533
Flanagan, L., Schmid, J., Ebert, M., Soucek, P., Kunicka, T., Liska, V., Bruha, J., Neary, P., Dezeeuw, N., Tommasino, M., et al. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2081-3 · Cited by 498
“the representation of bacteria in their vicinity [10,12,17].”
BackgroundRajilić‐Stojanović, M., Heilig, H. G. H. J., Molenaar, D., Kajander, K., Surakka, A., Smidt, H., & De Vos, W. M. (2009) · Environmental Microbiology · doi:10.1111/j.1462-2920.2009.01900.x · Cited by 484
“2NIZO Food Research, P.O Box 20, 6710 BA Ede, the”
BackgroundDysbiosis Signature of Fecal Microbiota in Colorectal Cancer Patients
Wu, N., Yang, X., Zhang, R., Li, J., Xiao, X., Hu, Y., Chen, Y., Yang, F., Lu, N., Wang, Z., et al. (2013) · Microbial Ecology · doi:10.1007/s00248-013-0245-9 · Cited by 454
“demonstrated that the Clostridium leptum and Clostridium coccoides subgroups were specific to CRC and polyposis [6].”
BackgroundSelf-citationMolecular characterization of mucosal adherent bacteria and associations with colorectal adenomas
Shen, X. J., Rawls, J. F., Randall, T. A., Burcall, L., Mpande, C., Jenkins, N., Jovov, B., Abdo, Z., Sandler, R. S., & Keku, T. O. (2010) · Gut Microbes · doi:10.4161/gmic.1.3.12360 · Cited by 418
Gut microbiome and type 2 diabetes: where we are and where to go?
Sharma, S., & Tripathi, P. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.10.003 · Cited by 446
Role of the gut microbiota in defining human health
Fujimura, K. E., Slusher, N. A., Cabana, M. D., & Lynch, S. V. (2010) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.10.14 · Cited by 421
Wlodarska, M., Willing, B., Keeney, K. M., Menendez, A., Bergstrom, K. S., Gill, N., Russell, S. L., Vallance, B. A., & Finlay, B. B. (2011) · Infection and Immunity · doi:10.1128/iai.01104-10 · Cited by 382
“Further, there are significant differences in microbiota compositions of inflammatory bowel disease (IBD) patients and healthy individuals, further implicating microbial factors in the initiation and perpetuation of colitis (17, 19, 32, 46).”
BackgroundBreast cancer in postmenopausal women is associated with an altered gut metagenome
Zhu, J., Liao, M., Yao, Z., Liang, W., Li, Q., Liu, J., Yang, H., Ji, Y., Wei, W., Tan, A., et al. (2018) · Microbiome · doi:10.1186/s40168-018-0515-3 · Cited by 377
Malla, M. A., Dubey, A., Kumar, A., Yadav, S., Hashem, A., & Allah, E. F. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02868 · Cited by 366
Human Gut Microbiota: Repertoire and Variations
Lagier, J., Million, M., Hugon, P., Armougom, F., & Raoult, D. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00136 · Cited by 347
“…between gut microbiota composition and diverse diseases, such as irritable bowel syndrome (Kassinen et al., 2007), polyposis or colorectal cancer (Scanlan et al., 2008), necrotizing enterocolitis (Siggers et al., 2008), Crohn’s disease (De Hertogh et al., 2006; Manichanh et al., 2006; Scanlan et…”
Davis, L. M. G., Martínez, I., Walter, J., Goin, C., & Hutkins, R. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025200 · Cited by 329
“Aberrations in the gut microbiota have been linked to several complex diseases, including inflammatory bowel disease [4,7,8,9], obesity, atherosclerosis and cardiovascular disease [10,11,12,13], type 2 diabetes [14], colorectal cancer [15,16,17], arthritis [18], and allergic diseases [4,19].”
BackgroundMicrobial symbionts accelerate wound healing via the neuropeptide hormone oxytocin
Poutahidis, T., Kearney, S. M., Levkovich, T., Qi, P., Varian, B. J., Lakritz, J. R., Ibrahim, Y. M., Chatzigiagkos, A., Alm, E. J., & Erdman, S. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078898 · Cited by 310
Interplay between diet, gut microbiota, epigenetic events, and colorectal cancer
Bultman, S. J. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500902 · Cited by 275
Mira‐Pascual, L., Cabrera‐Rubio, R., Ocon, S. M., Costales, P., Parra, A., Suárez, A., Morís, F., Rodrigo, L., Mira, Á., & Collado, M. C. (2014) · Journal of Gastroenterology · doi:10.1007/s00535-014-0963-x · Cited by 269
Bae, S., Ulrich, C. M., Neuhouser, M. L., Malysheva, O., Bailey, L. B., Xiao, L., Brown, E. C., Cushing-Haugen, K. L., Zheng, Y., Cheng, T.-Y. D., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1835 · Cited by 253
“healthy individuals, increased number and diversity as well as the decreased stability of a colonic 278 bacterial group, Clostridium, have been characterized in patients with CRC (16, 42).”
Azcárate-Peril, M. A., Sikes, M. L., & Bruno-Bárcena, J. M. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00110.2011 · Cited by 260
“This study also demonstrated a higher overall diversity in adenoma samples, which was previously shown for two specific Clostridium species in an earlier study conducted in fecal samples of patients with CRC (236).”
ResultEmerging roles of the microbiome in cancer
Bultman, S. J. (2014) · Carcinogenesis · doi:10.1093/carcin/bgt392 · Cited by 239
Microbiota and Metabolome Associated with Immunoglobulin A Nephropathy (IgAN)
Angelis, M. D., Montemurno, E., Píccolo, M. C., Vannini, L., Lauriero, G., Maranzano, V., Gozzi, G., Serrazanetti, D. I., Dalfino, G., Gobbetti, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099006 · Cited by 244
“An alteration of the fecal microbiota composition, which was related to an increased level of FAA, was described in colon carcinoma patients [65].”
BackgroundYap, I. K. S., Li, J. V., Saric, J., Martin, F., Davies, H., Wang, Y., Wilson, I. D., Nicholson, J. K., Utzinger, J., Marchesi, J. R., et al. (2008) · Journal of Proteome Research · doi:10.1021/pr700864x · Cited by 235
Self-citationHost immunoglobulin G selectively identifies pathobionts in pediatric inflammatory bowel diseases
Armstrong, H., Alipour, M., Valcheva, R. S., Bording‐Jorgensen, M., Jovel, J., Zaidi, D., Shah, P., Lou, Y., Ebeling, C., Mason, A. L., et al. (2019) · Microbiome · doi:10.1186/s40168-018-0604-3 · Cited by 228
Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations
Sinha, R. R., Ahn, J., Sampson, J. N., Shi, J., Yu, G., Xiong, X., Hayes, R. B., & Goedert, J. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152126 · Cited by 226
Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans
Sanapareddy, N., Legge, R. M., Jovov, B., McCoy, A. N., Burcal, L., Araújo-Pérez, F., Randall, T. A., Galanko, J. A., Benson, A. K., Sandler, R. S., et al. (2012) · The ISME Journal · doi:10.1038/ismej.2012.43 · Cited by 219
“, 2005) has also been frequently proposed as a critical factor in CRC development (Huycke and Gaskins, 2004; Scanlan et al., 2008).”
BackgroundThe intestinal microbiota: its role in health and disease
Biedermann, L., & Rogler, G. (2015) · European Journal of Pediatrics · doi:10.1007/s00431-014-2476-2 · Cited by 227
“specific differences, such as 16S RNA [46, 161, 167, 168].”
Mucosal microbiota of intestinal polyps reveals putative biomarkers of colorectal cancer
Mangifesta, M., Mancabelli, L., Milani, C., Gaiani, F., de’Angelis, N., de’Angelis, G. L., van Sinderen, D., Ventura, M., & Turroni, F. (2018) · Scientific Reports · doi:10.1038/s41598-018-32413-2 · Cited by 217
The gastrointestinal microbiota and colorectal cancer
Keku, T. O., Dulal, S., Deveaux, A. E., Jovov, B., & Han, X. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00360.2012 · Cited by 207
“Lu et al. 2014 (88a) SPF C57BL/6 mice, AOM/DSS induced CRC Salmonella typhimirium AvrA- inflammationassociated CRC Salmonella-expressing AvrA activates -catenin, significantly increased CRC. Zhu et al. 2014 (178) Wister rats, 1,2-dimethylhydrazine (DMH)-induced CRC Microbial composition in lumen Altered microbial comp…”
BackgroundInfluentialShifts in the Fecal Microbiota Associated with Adenomatous Polyps
Hale, V. L., Chen, J., Johnson, S. P., Harrington, S. C., Yab, T. C., Smyrk, T. C., Nelson, H., Boardman, L. A., Druliner, B. R., Levin, T. R., et al. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0337 · Cited by 202
Role of colonic microbiota in colorectal carcinogenesis: A systematic review
Borges‐Canha, M. (2015) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2015.3830/2015 · Cited by 195
Ohigashi, S., Sudo, K., Kobayashi, D., Takahashi, O., Takahashi, T., Asahara, T., Nomoto, K., & Onodera, H. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2526-4 · Cited by 186
Tao, S., Li, L., Li, L., Liu, Y., Ren, Q., Shi, M., Liu, J., Jiang, J., Ma, H., Huang, Z., et al. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01316-7 · Cited by 180
Self-citationInvestigating the biological and clinical significance of human dysbioses
Frank, D. N., Zhu, W., Sartor, R. B., & Li, E. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.06.005 · Cited by 182
“Indeed, recent applications of culture-independent sequencing technologies to studies of human health and disease have revealed dysbioses associated with diverse conditions, including antibiotic-associated diarrhea [5, 6], bacterial vaginosis [7–9], celiac disease [10], colorectal cancer [11, 12], cystic fibrosis [13,…”
BackgroundThe controversial role of Enterococcus faecalis in colorectal cancer
Almeida, C. V. D., Taddei, A., & Amedei, A. (2018) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284818783606 · Cited by 174
Gastrointestinal cancers: Influence of gut microbiota, probiotics and prebiotics
Serban, D. E. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.08.013 · Cited by 162
Jacobs, D. M., Gaudier, E. A., van Duynhoven, J., & Vaughan, E. E. (2009) · Current Drug Metabolism · doi:10.2174/138920009787048383 · Cited by 168
“In another study investigating the gut ecosystem in subjects with colorectal cancer and with adenomatous polyposis (known to be at high risk of developing colorectal cancer), significant alterations including increased diversity of the Clostridium leptum and Clostridium coccoides subgroups and elevated levels of amino…”
ResultUnderstanding the role of the gut ecosystem in diabetes mellitus
Aw, W., & Fukuda, S. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12673 · Cited by 158
“health but also implicated in the pathogenesis of numerous metabolic diseases such as obesity (24-26), diabetes (26-29) chronic kidney disease (30, 31) and atherosclerosis (32-34); intestinal diseases (21) like inflammatory bowel diseases (35), colorectal cancer (36-38).”
BackgroundBlastocystis: getting to grips with our guileful guest
Scanlan, P. D., & Stensvold, C. R. (2013) · Trends in Parasitology · doi:10.1016/j.pt.2013.08.006 · Cited by 165
Self-citationGut microbiome and metabolic diseases
Fukuda, S., & Ohno, H. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0399-z · Cited by 156
“On the other hand, imbalance of the gut microbiota, or dysbiosis, can predispose individuals to a variety of disease states ranging from gut-intrinsic disorders such as inflammatory bowel diseases [22–24], Crohn’s disease and ulcerative colitis, and colonic cancer [25, 26] to systemic diseases such as allergic disease…”
BackgroundGut Microbiota and Its Mysteries
Pushpanathan, P., Mathew, G. S., Selvarajan, S., Seshadri, K., & Srikanth, P. (2019) · Indian Journal of Medical Microbiology · doi:10.4103/ijmm.ijmm_19_373 · Cited by 162
New perspectives on probiotics in health and disease
Daliri, E. B., & Lee, B. H. (2015) · Food Science and Human Wellness · doi:10.1016/j.fshw.2015.06.002 · Cited by 158
Boleij, A., & Tjalsma, H. (2012) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/j.1469-185x.2012.00218.x · Cited by 153
The human gut microbiome, a taxonomic conundrum
Sankar, S. A., Lagier, J., Pontarotti, P., Raoult, D., & Fournier, P. (2015) · Systematic and Applied Microbiology · doi:10.1016/j.syapm.2015.03.004 · Cited by 157
Unravelling the involvement of gut microbiota in type 2 diabetes mellitus
Arora, A., Behl, T., Sehgal, A., Singh, S., Sharma, N., Bhatia, S., Sobarzo‐Sánchez, E., & BUNGAU, S. G. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119311 · Cited by 147
Probiotics in colorectal cancer (CRC) with emphasis on mechanisms of action and current perspectives
Kahouli, I., Tomaro-Duchesneau, C., & Prakash, S. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.048975-0 · Cited by 144
Review article: fungal microbiota and digestive diseases
Wang, Z., Yang, Y., Stefka, A. T., Sun, G., & Peng, L. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12665 · Cited by 138
Fusobacterium and Colorectal Cancer
Zhou, Z., Chen, J., Yao, H., & Hu, H. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00371 · Cited by 140
“Particularly, colonic dysbiosis has been associated with CRC (17) (12, 18) (19) (20).”
BackgroundGut Microbes, Diet, and Cancer
Hullar, M. A. J., Burnett‐Hartman, A. N., & Lampe, J. W. (2013) · Cancer treatment and research · doi:10.1007/978-3-642-38007-5_22 · Cited by 138
Costabile, A., Fava, F., Röytiö, H., Forssten, S. D., Olli, K., Klievink, J., Rowland, I. R., Ouwehand, A. C., Rastall, R. A., Gibson, G. R., et al. (2012) · British Journal of Nutrition · doi:10.1017/s0007114511005782 · Cited by 135
“Little information is available on increased microbial diversity; however, the research of Scanlan et al.((44)) associated increased diversity with colonic polyps and cancer formation.”
BackgroundInfluentialLRLSHMDA: Laplacian Regularized Least Squares for Human Microbe–Disease Association prediction
Wang, F., Huang, Z.-A., Chen, X., Zhu, Z., Wen, Z., Zhao, J., & Yan, G. (2017) · Scientific Reports · doi:10.1038/s41598-017-08127-2 · Cited by 126
“The dramatic increase of Clostridium difficile (3th in the prediction list) and C . coccoides (4th in the prediction list) was a potential pathogenic factor for triggering colorectal carcinoma 72 .”
BackgroundHuman intestinal microbiota: cross-talk with the host and its potential role in colorectal cancer
Candela, M., Guidotti, M., Fabbri, A., Brigidi, P., Franceschi, C., & Fiorentini, C. (2010) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2010.501760 · Cited by 117
“Even if relatively few studies have been carried out, there is an increasing evidence of the potential role of the intestinal microbiota in colorectal carcinogenesis (O’Keefe, 2008; Scanlan et al. 2008; Davis and Milner., 2009; Mai et al. 2009; O’Kneefe et al. 2009; Uronis et al. 2009).”
BackgroundThe Gut Microbiota and Human Health with an Emphasis on the Use of Microencapsulated Bacterial Cells
Prakash, S., Tomaro-Duchesneau, C., Saha, S., & Cantor, A. (2011) · BioMed Research International · doi:10.1155/2011/981214 · Cited by 117
Diet Effects in Gut Microbiome and Obesity
Chen, J., He, X., & Huang, J. (2014) · Journal of Food Science · doi:10.1111/1750-3841.12397 · Cited by 121
Maier, E., Anderson, R. C., & Roy, N. C. (2014) · Nutrients · doi:10.3390/nu7010045 · Cited by 123
“The health of humans is impacted by the symbiotic relationship with their microbiota, while a dysbiosis of the resident microbiota is associated with various disorders, such as inflammatory bowel diseases [1–3], colorectal cancer [4,5], coeliac disease [6] and obesity [7].”
BackgroundHong, P., Croix, J. A., Greenberg, E., Gaskins, H. R., & Mackie, R. I. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025042 · Cited by 107
“To illustrate, numerous recent studies examined the gut microbiota present in various disease models: obesity [2,3,4,5], and gastrointestinal diseases including ulcerative colitis and colorectal cancer [6,7,8].”
Background“Omics” in pharmaceutical research: overview, applications, challenges, and future perspectives
Yan, S., Liu, R., Jin, H., Liu, X., Ye, J., Shan, L., & Zhang, W. (2015) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(15)60002-4 · Cited by 115
“Metagenomics studies have also demonstrated an imbalanced microbiota composition in various diseases, such as Crohn's disease ([13]), necrotizing enterocolitis ([14]), polyposis or colorectal cancer ([15]), and type 2 diabetes ([16]).”
BackgroundCharacterization of the intestinal microbiota and its interaction with probiotics and health impacts
de Almada, C. N., de Almada, C. N., Martinez, R. C. R., & Sant’Ana, A. S. (2015) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-6582-5 · Cited by 102
Is It Time to Use Probiotics to Prevent or Treat Obesity?
Brusaferro, A., Cozzali, R., Orabona, C., Biscarini, A., Farinelli, E., Cavalli, E., Grohmann, U., Principi, N., & Esposito, S. (2018) · Nutrients · doi:10.3390/nu10111613 · Cited by 106
“Dysbiosis has been described in irritable bowel syndrome [6], inflammatory bowel disease [7,8], colorectal cancer [9,10], allergic diseases [11], non-alcoholic steatohepatitis [12,13], arteriosclerotic diseases [14,15], several neurologic diseases [16], and metabolic syndromes [17,18], most notably diabetes and obesit…”
BackgroundLinking pollution and cancer in aquatic environments: A review
Baines, C., Lerebours, A., Frédéric Thomas, A., Fort, J., Kreitsberg, R., Gentès, S., Meitern, R., Saks, L., Újvári, B., Giraudeau, M., et al. (2021) · Environment International · doi:10.1016/j.envint.2021.106391 · Cited by 105
Diet, fecal water, and colon cancer - development of a biomarker
Pearson, J. R., Gill, C. I., & Rowland, I. R. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.2009.00224.x · Cited by 103
Dheer, R., Patterson, J., Dudash, M., Stachler, E. N., Bibby, K. J., Stolz, D. B., Shiva, S., Wang, Z., Hazen, S. L., Barchowsky, A., et al. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.10.020 · Cited by 95
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript (Scanlan et al., 2008; Spencer et al., 2011).”
BackgroundMarchesi, J. R. (2011) · Environmental Microbiology · doi:10.1111/j.1462-2920.2011.02574.x · Cited by 97
“The most common species and 16S rRNA gene sequence isolated from the distal gut come from the Euryarchaeota and in particular the Methanobacteriaceae family (Scanlan et al., 2008a; Dridi et al., 2009) with Methanobrevibacter smithii and Methanosphaera stadtmanae the two predominant Archaea found.”
BackgroundSelf-citationZhu, G., Huang, Q., Huang, Y., Zheng, W., Jin, H., Yang, S., Zhuang, J., Wang, J., & Ye, J. (2016) · Oncotarget · doi:10.18632/oncotarget.12449 · Cited by 91
“In colorectal cancer, the intestinal microbiota and their metabolic microenvironment are usually altered and a significantly increased diversity of Gram-negative bacteria subgroups was noted [13, 14].”
BackgroundCompositional dynamics of the human intestinal microbiota with aging: Implications for health
Lakshminarayanan, B., Stanton, C., O’Toole, P. W., & Ross, R. P. (2014) · The journal of nutrition health & aging · doi:10.1007/s12603-014-0549-6 · Cited by 93
“…observed that colon cancer patients exhibit a significantly increased diversity and reduced stability of clostridia compared to healthy individuals (89). interestingly, sobhani et al demonstrated (using qPCr) that all the bacterial species belonging to the Bacteroides/Prevotella group were more…”
Gut microbiome of Moroccan colorectal cancer patients
Allali, I., Boukhatem, N., Bouguenouch, L., Hardi, H., Boudouaya, H. A., Cadenas, M. B., Ouldim, K., Amzazi, S., Azcárate-Peril, M. A., & Ghazal, H. (2018) · Medical Microbiology and Immunology · doi:10.1007/s00430-018-0542-5 · Cited by 90
“Our findings agree with previous studies that showed that Bacteroides were enriched in CRC patients [20, 34, 75].”
ResultUpper gastrointestinal microbiota and digestive diseases
Wang, Z.-K. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i10.1541 · Cited by 90
Sekelja, M., Berget, I., Næs, T., & Rudi, K. (2010) · The ISME Journal · doi:10.1038/ismej.2010.129 · Cited by 93
“Recent research has shown that human intestinal microbiota can be linked to obesity (Ley et al., 2006; Turnbaugh, 2006), allergies, inflammatory bowel disease (Frank et al., 2007) and colon cancer (Scanlan et al., 2008).”
BackgroundModerate Exercise Has Limited but Distinguishable Effects on the Mouse Microbiome
Lamoureux, E., Grandy, S. A., & Langille, M. G. I. (2017) · mSystems · doi:10.1128/msystems.00006-17 · Cited by 90
Diet, Microbiota, and Colorectal Cancer
Akin, H., & Tozun, N. A. (2014) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000252 · Cited by 86
Bamola, V. D., Ghosh, A., Kapardar, R. K., Lal, B., Cheema, S., Sarma, P. M., & Chaudhry, R. (2017) · Microbial Ecology in Health and Disease · doi:10.1080/16512235.2017.1322447 · Cited by 77
The gut microbiota and aging: interactions, implications, and interventions
Gyriki, D., Nikolaidis, C. G., Bezirtzoglou, E., Voidarou, C. C., Stavropoulou, E., & Tsigalou, C. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1452917 · Cited by 80
Shi, Y., Zhai, Q., Li, D., Mao, B., Liu, X., Zhao, J., Zhang, H., & Chen, W. (2017) · Microbiological Research · doi:10.1016/j.micres.2017.04.001 · Cited by 75
Fança‐Berthon, P., Hoebler, C., Mouzet, E., David-Sochard, A., & Michel, C. (2010) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3181d75d52 · Cited by 74
“On the one hand, this bacterial group has been associated with CRC or polyposis (25); on the other hand, the stimulation of these bacteria is now sometimes advised (21) because they include butyrate producers.”
BackgroundLi, Y., Wang, S., Sun, Y., Xu, W., Zheng, H., Wang, Y., Tang, Y., Gao, X., Song, C., Long, Y., et al. (2019) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2019.115726 · Cited by 71
Self-citationAssociation of plasma endotoxin, inflammatory cytokines and risk of colorectal adenomas
Kang, M. S., Edmundson, P., Araújo-Pérez, F., McCoy, A. N., Galanko, J. A., & Keku, T. O. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-91 · Cited by 69
“More recently, CRC has been linked to changes in the gut microbiota [2-5].”
BackgroundThe Role of the Microbiome in Gastrointestinal Cancer
Wroblewski, L. E., Peek, R. M., & Coburn, L. A. (2016) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2016.04.010 · Cited by 79
“shown decreased temporal stability, with increased diversity of theClostridium leptum and C coccoides subgroups versus control subjects, although not between patients with CRC versus colonic polyps.(60) Studies assessing mucosa-associated bacteria”
Genomics and metagenomics in medical microbiology
Padmanabhan, R., Mishra, A. K., Raoult, D., & Fournier, P. (2013) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2013.10.006 · Cited by 67
“, 2008) polyposis or colorectal cancer (Scanlan et al., 2008), type II diabetes (Larsen et al.”
BackgroundPossible cancer-causing capacity of COVID-19: Is SARS-CoV-2 an oncogenic agent?
Jahankhani, K., Ahangari, F., Adcock, I. M., & Mortaz, E. (2023) · Biochimie · doi:10.1016/j.biochi.2023.05.014 · Cited by 67
Differential susceptibility to colorectal cancer due to naturally occurring gut microbiota
Ericsson, A. C., Akter, S., Hanson, M. M., Busi, S. B., Parker, T. W., Schehr, R., Hankins, M. A., Ahner, C. E., Davis, J. W., Franklin, C. L., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5604 · Cited by 62
“In one of the first studies using culture-independent methods to compare the GM of patients diagnosed with CRC and healthy controls, an association was demonstrated between the incidence of CRC and increased overall microbial diversity [7].”
BackgroundResultThe Role of the gut Microbiome in the Pathogenesis and Treatment of Obesity
Okeke, F. C., Roland, B. C., & Mullin, G. E. (2014) · Global Advances in Health and Medicine · doi:10.7453/gahmj.2014.018 · Cited by 63
Liszt, K., Zwielehner, J., Handschur, M., Hippe, B., Thaler, R., & Haslberger, A. G. (2009) · Annals of Nutrition and Metabolism · doi:10.1159/000229505 · Cited by 61
“The highly diverse microbiota of the human gastrointestinal tract has been associated with colorectal cancer [”
BackgroundCuív, P. Ó., de Cárcer, D. A., Jones, M., Klaassens, E. S., Worthley, D. L., Whitehall, V., Kang, S., McSweeney, C. S., Leggett, B., & Morrison, M. (2010) · Microbial Ecology · doi:10.1007/s00248-010-9771-x · Cited by 60
Notes on the practical utility of OPLS
Tapp, H. S., & Kemsley, E. K. (2009) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2009.08.006 · Cited by 60
Tejesvi, M. V., Uhari, M. K., Tapiainen, T., Pirttilä, A. M., Suokas, M., Lantto, U., Koivunen, P. T., & Renko, M. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2623-y · Cited by 60
The Human Gutome: Nutrigenomics of the Host–Microbiome Interactions
Dimitrov, D. V. (2010) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2010.0109 · Cited by 58
Altered Tissue Metabolites Correlate with Microbial Dysbiosis in Colorectal Adenomas
Nugent, J. L., McCoy, A. N., Addamo, C. J., Jia, W. P., Sandler, R. S., & Keku, T. O. (2014) · Journal of Proteome Research · doi:10.1021/pr4009783 · Cited by 58
Effects of Diet on Gut Microbiota Profile and the Implications for Health and Disease
Lee, Y. K. (2013) · Bioscience of Microbiota Food and Health · doi:10.12938/bmfh.32.1 · Cited by 58
Siqueira, J. F., Jr., Rôças, I. N., Debelian, G., do Carmo, F. L., Paiva, S. S. M., Alves, F. R. F., & Rosado, A. S. (2008) · Journal of Endodontics · doi:10.1016/j.joen.2008.08.037 · Cited by 54
Metadata
- Authors
- Scanlan, P. D., Shanahan, F., Clune, Y., Collins, J. K., O'Sullivan, G. C., O'Riordan, M., Holmes, E., Wang, Y., & Marchesi, J. R.
- Affiliations
- University College Cork (IE)
- Imperial College London (GB)
- Corresponding author
- Marchesi, Julian R.
- ORCID
- Venue
- Environmental Microbiology
- Publisher
- Wiley
- Published
- 2008-01-25
- Volume
- 10
- Issue
- 3
- Pages
- 789-798
- ISSN
- 1462-2912 (ISSN-L)
- 1462-2920
- OpenAlex
- W2146480823
- Cited by
- 245
- References
- 47
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 4 · 2023: 6 · 2022: 8 · 2021: 12 · 2020: 10 · 2019: 14 · 2018: 20 · 2017: 13 · 2016: 17 · 2015: 23 · 2014: 22 · 2013: 26 · 2012: 12
- FWCI
- 6.96
- Type
- journal article
- Language
- en
- Update notices
- erratum (2008-04-04)
- Open access
- closed
- Locations
- Environmental Microbiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Health Research Board
- Higher Education Authority
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- gut microbiota, colorectal cancer, adenomatous polyposis, polypectomy, microbial diversity, temporal stability, Clostridium leptum, Clostridium coccoides, 16S rRNA gene, RISA, metabolomics, cancer etiology
- MeSH terms
- Clostridium, DNA, Bacterial, Electrophoresis, Polyacrylamide Gel, Female, Humans, Intestines, Male, Adenomatous Polyposis Coli, RNA, Ribosomal, 16S, Colorectal Neoplasms, DNA, Ribosomal Spacer, Gastrointestinal Tract, Biodiversity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review